Image

Sleep Health Enhancement in Older Adults to Address Frailty

Recruiting
65 years of age
Both
Phase 1

Powered by AI

Overview

The objective of the proposed study is to tailor a sleep health enhancement intervention to older adults and assess preliminary efficacy on reducing frailty in older adults. This pilot study will be conducted in two stages. In the treatment development stage, we will recruit n=10 older individuals age ≥65 with poor sleep health (≤ 7 on the Ru-SATED self-report questionnaire) to assess acceptability and tailor the sleep health enhancement intervention for older adults. In the pilot study stage to assess preliminary efficacy of the tailored sleep health enhancement intervention, n=30 older adults with poor sleep health will be randomly assigned to a 4-week 1x/week, telehealth-delivered sleep health enhancement intervention or to a wait-list control condition. Participants will wear wrist-worn actigraphy, complete sleep, frailty, and quality of life questionnaires at baseline and reassessments.

Eligibility

Inclusion Criteria:

  • ≥65 years old
  • ≤ 7 on the RU-SATED self-report questionnaire
  • MMSE ≥25 and AD8 <3

Exclusion Criteria:

  • Known untreated sleep disorder (such as sleep apnea or restless leg syndrome)
  • >3 on the STOP BANG indicating increased risk of sleep apnea
  • Evidence of restless legs syndrome on RLS-Diagnosis Index
  • Evidence of circadian rhythm sleep-wake disorder
  • Evidence of parasomnia
  • Regular use (>2x/week) of prescription or over-the-counter medications to improve sleep
  • Score of ≥15 on the Patient Health Questionnaire (PHQ-9) indicating severe depression or endorse any suicidal ideation (answer 1, 2 or 3 on #9 of the PHQ-9)
  • Score of ≥10 on the Generalized Anxiety Disorder (GAD-7) indicating moderate to severe anxiety
  • Self-report of current or history (up to 2 years) of drug or alcohol abuse based on the DSM-V criteria
  • History of nervous system disorder such as stroke or Parkinson's disease
  • Severe mental illness such as schizophrenia or bipolar disorder
  • Current or history (within 5 years) of shift work including hours of midnight-4am
  • Is currently receiving a behavioral sleep health intervention

Study details

Frailty

NCT05968820

University of Kansas Medical Center

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.